Research statistics
TB-500 (Thymosin Beta-4 fragment) research: publications and trials
At a glance
Publications, all years
21
Since 2012
Publications in 2026 so far
9
Through November 1, 2026
Human clinical research
4.8%
1 of 21 classified
Registered clinical trials
1
ClinicalTrials.gov
Randomized controlled trials
0
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
66.7%
5 animal · 9 in vitro · 0 computational
Records that only mention it
11
Not counted above
Status in the library: Research only. Groups: Tissue-repair peptides.
What to keep in mind
- Fewer than three randomized controlled trials are indexed.
- Fewer than 25 publications are indexed, so year-to-year changes are not meaningful.
Publications by year
TB-500 (Thymosin Beta-4 fragment) publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Total |
|---|---|---|---|---|
| 2012 | 0 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 0 | 1 |
| 2022 | 0 | 2 | 0 | 2 |
| 2024 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 2 | 0 | 2 |
| 2026 (to date) | 1 | 2 | 6 | 9 |
Study types
| In vitro study | 9 |
|---|---|
| Review | 6 |
| Animal study | 5 |
| Case report | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Tissue repair | 11 |
|---|---|
| Musculoskeletal | 5 |
| Neurological and mental health | 5 |
| Metabolic health | 4 |
| Endocrinology | 3 |
| Immune system | 3 |
| Cardiovascular | 2 |
| Dermatology | 2 |
| Cognitive health | 1 |
| Longevity and aging | 1 |
| Reproductive and sexual health | 1 |
Registered clinical trials
A registration is not a result.
Recruiting: 1
Phase 1 / Phase 2: 1
| Trial | Status | Phase | Started | Results |
|---|---|---|---|---|
| TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVDNCT07487363 · 80 enrolled | Recruiting | Phase 1, Phase 2 | 2026-02 | — |
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
No human trial, systematic review or meta-analysis of TB-500 (Thymosin Beta-4 fragment) is indexed.
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.
Journal of separation science · December 15, 2015 · In vitro study · cited 48 times
PMID 26578461 · DOI 10.1002/jssc.201501060 · In vitro studies
- Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.
Journal of chromatography. A · September 23, 2012 · Animal study · cited 45 times
PMID 23084823 · DOI 10.1016/j.chroma.2012.09.043 · Animal studies
- Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
Analytical and bioanalytical chemistry · January 15, 2013 · Animal study · cited 40 times
PMID 23318763 · DOI 10.1007/s00216-012-6697-9 · Animal studies
- In vitro models for metabolic studies of small peptide hormones in sport drug testing.
Journal of peptide science : an official publication of the European Peptide Society · December 3, 2014 · In vitro study · cited 39 times · open access
PMID 25469748 · DOI 10.1002/psc.2710 · In vitro studies
- Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential.
Drug testing and analysis · September 7, 2012 · In vitro study · cited 39 times · open access
PMID 22962027 · DOI 10.1002/dta.1402 · In vitro studies
Latest publications
- Investigational Peptides in Orthopaedic Practice: Evidence, Safety, and Patient Counseling for BPC-157, Thymosin Beta-4, and TB-500.
The Journal of the American Academy of Orthopaedic Surgeons · October 27, 2026 · Review · cited 0 times
PMID 42937313 · DOI 10.5435/jaaos-d-26-00049 · Reviews and meta-analyses
- Case Report: Regenerative peptides for Inferior alveolar nerve injury: a narrative review with hypothesis-generating three clinical cases.
Frontiers in oral health · September 30, 2026 · Case report · cited 0 times · open access
PMID 42876687 · DOI 10.3389/froh.2026.1907109 · Human clinical research
- Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.
Current pain and headache reports · August 24, 2026 · Review · cited 0 times
PMID 42635865 · DOI 10.1007/s11916-026-01542-z · Reviews and meta-analyses
- Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
The American journal of sports medicine · August 11, 2026 · Review · cited 1 times · open access
PMID 42578445 · DOI 10.1177/03635465261464420 · Reviews and meta-analyses
- Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.
The Analyst · July 27, 2026 · In vitro study · cited 0 times
PMID 42328738 · DOI 10.1039/d6an00455e · In vitro studies
- Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.
Joint diseases and related surgery · July 23, 2026 · Animal study · cited 0 times · open access
PMID 42542926 · DOI 10.52312/jdrs.2026.2951 · Animal studies
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Sports medicine (Auckland, N.Z.) · April 12, 2026 · Review · cited 8 times · open access
PMID 41966639 · DOI 10.1007/s40279-026-02437-0 · Reviews and meta-analyses
- Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Frontiers in aging · April 7, 2026 · Review · cited 4 times · open access
PMID 42021992 · DOI 10.3389/fragi.2026.1790247 · Reviews and meta-analyses
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
The American journal of sports medicine · January 1, 2026 · Review · cited 12 times
PMID 41476424 · DOI 10.1177/03635465251357593 · Reviews and meta-analyses
- Thymosin β4-derived peptides alleviate neuroinflammation and neurite atrophy in both in vitro models and in vivo 5 × FAD mice: A potential therapy for memory improvement in Alzheimer's disease.
International immunopharmacology · December 23, 2025 · Animal study · cited 1 times
PMID 41443105 · DOI 10.1016/j.intimp.2025.116097 · Animal studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Ac-LKKTETQ; TB-500
((TITLE_ABS:"Ac-LKKTETQ" OR CHEM:"Ac-LKKTETQ") OR (TITLE_ABS:"TB-500" OR CHEM:"TB-500" OR TITLE_ABS:"TB500" OR CHEM:"TB500")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 2). TB-500 (Thymosin Beta-4 fragment) research statistics (Version weekly-2026-11-01) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/tb-500